Ronald Evans

Ronald Evans

Direktör/Styrelseledamot på
The Salk Institute for Biological Studies
76 år
Health Technology
Commercial Services
Consumer Services

Profil

Ronald M.
Evans
is the founder of Ligand Pharmaceuticals, Inc. (1987), Syndax Pharmaceuticals, Inc. (2005), Synchronicity Pharma, Inc. (2008), Mitobridge, Inc. (2013), and Metacrine, Inc. (2014).
He is also the founder of Xenopharm, Inc., X-Ceptor Therapeutics, Inc., XTuit Pharmaceuticals, Inc. Dr. Evans's current jobs include Director & Professor at The Salk Institute for Biological Studies, Director at American Association for Cancer Research, Member at National Academy of Sciences, Member at American Academy of Arts & Sciences, and Member at National Academy of Medicine (United States).
Dr. Evans received his doctorate degree from the University of California, Los Angeles in 1974 and his undergraduate degree from the same university in 1970.

Aktiva positioner av Ronald Evans

FöretagPositionStart
Direktör/Styrelseledamot -
Företagsledare/Principal 2010-01-25
Företagsledare/Principal 2010-01-25
Företagsledare/Principal 2010-01-25
Direktör/Styrelseledamot -

Tidigare kända positioner av Ronald Evans

FöretagPositionSlut
METACRINE, INC. Grundare 2023-03-23
Grundare -
Grundare -
Grundare -
░░░░░░░░░░ ░░░░ ░░░░░░░░ -
Se detaljerna i Ronald Evanss erfarenhet

Ronald Evanss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

88

Första gradens relationer

14

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag14

Health Technology

Consumer Services

Health Technology

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Ronald Evans
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU